Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current Advances in RNA Therapeutics for Human Diseases
Hannah Zogg, Rajan Singh, Seungil Ro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2736-2736
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management
Sunitha Shyam Sunder, Umesh C. Sharma, Saraswati Pokharel
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 174
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 65
A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer Therapy
Jiaying Zhang, Bo Chen, Chunyuan Gan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7605-7635
Open Access | Times Cited: 45
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 43
tRNA-derived small RNAs in human cancers: roles, mechanisms, and clinical application
Manli Zhou, Xiaoyun He, Jing Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Breaking the mold with RNA—a “RNAissance” of life science
Charles H. Jones, John R. Androsavich, N. So, et al.
npj Genomic Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
Sumit Gangopadhyay, Kiran R. Gore
RNA Biology (2022) Vol. 19, Iss. 1, pp. 452-467
Open Access | Times Cited: 47
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry
Aaron Debon, Elina Siirola, Radka Šnajdrová
JACS Au (2023) Vol. 3, Iss. 5, pp. 1267-1283
Open Access | Times Cited: 30
Three ‘E’ challenges for siRNA drug development
Shuai Guo, Jun Zhang, Yuanyu Huang
Trends in Molecular Medicine (2023) Vol. 30, Iss. 1, pp. 13-24
Open Access | Times Cited: 25
Rational design and combinatorial chemistry of ionizable lipids for RNA delivery
Yue Xu, Alex Golubovic, Shufen Xu, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 28, pp. 6527-6539
Closed Access | Times Cited: 24
Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, et al.
Cardiology and Therapy (2024) Vol. 13, Iss. 1, pp. 39-67
Open Access | Times Cited: 10
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
David Valle‐García, Verónica Pérez de la Cruz, Itamar Flores, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2464-2464
Open Access | Times Cited: 9
Analysis revealed the molecular mechanism of oxidative stress-autophagy-induced liver injury caused by high alkalinity: integrated whole hepatic transcriptome and metabolome
Xinchi Shang, Longwu Geng, Hui Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Dual Roles of miR-10a-5p and miR-10b-5p as Tumor Suppressors and Oncogenes in Diverse Cancers
Rajan Singh, Se Eun Ha, Tae Yang Yu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 415-415
Open Access | Times Cited: 1
Immune response to the components of lipid nanoparticles for ribonucleic acid therapeutics
Sunny P. Chen, Anna K. Blakney
Current Opinion in Biotechnology (2023) Vol. 85, pp. 103049-103049
Open Access | Times Cited: 17
Characterization of mRNA therapeutics
Guilherme J. Guimaraes, Jaeah Kim, Michael G. Bartlett
Mass Spectrometry Reviews (2023) Vol. 43, Iss. 5, pp. 1066-1090
Open Access | Times Cited: 16
Contrastive pre-training and 3D convolution neural network for RNA and small molecule binding affinity prediction
Saisai Sun, Lin Gao
Bioinformatics (2024) Vol. 40, Iss. 4
Open Access | Times Cited: 7
Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders
Narges Naimi, Homa Seyedmirzaei, Zahra Hassannejad, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116691-116691
Open Access | Times Cited: 7
An Endosomal Escape Trojan Horse Platform to Improve Cytosolic Delivery of Nucleic Acids
Steven Narum, Brendan R. Deal, Hiroaki Ogasawara, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6186-6201
Open Access | Times Cited: 6
mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 6
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor
Yi Li, José L. Mondaza-Hernández, David S. Moura, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102154-102154
Open Access | Times Cited: 5
Osteosarcoma in a ceRNET perspective
Nicola Mosca, Nicola Alessio, Alessandra Di Paola, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 5
A review on the recent advances of interaction studies of anticancer metal-based drugs with therapeutic targets, DNA and RNAs
Huzaifa Yasir Khan, Mohammad Fawad Ansari, Sartaj Tabassum, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104055-104055
Closed Access | Times Cited: 5
Non-Coding RNAs Regulating Mitochondrial Functions and the Oxidative Stress Response as Putative Targets against Age-Related Macular Degeneration (AMD)
Juha M. T. Hyttinen, Janusz Błasiak, Kai Kaarniranta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2636-2636
Open Access | Times Cited: 15
Research progress on non-protein-targeted drugs for cancer therapy
Yiwen Zhang, Lu Lu, Feifeng Song, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top